Search
for
Sort by
Research 361–390 of 1000+
- Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
- Differential risk for COVID-19 in the first wave of the disease (February-April 2020) among migrants from several areas of the world living in Alcorcón (Spain): A population-based cohort study
- Brazilian pulmonology guidelines on Delphi panel for post-coronavirus disease 2019
- Correlation between Androgenetic Alopecia and Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection in China
- Bioprospecting of Potential Inhibitors of 5alpha Reductase 2 Inhibitors from Relevant Ethno-pharmacological Plants via In Silico Techniques
- Resolution of advanced conjunctival squamous cell carcinoma with cemiplimab immunotherapy, IFNα-2b, and retinoic acid treatment over 2 years of follow-up
- Investigating self-reported hair loss following covid-19 infection in the Iraqi population
- A Comment on Coronavirus Disease 2019 and the Hair
- Associations of telogen effluvium with coronavirus disease 2019 and research progress in its diagnosis and treatment
- Bacillus Calmette-Guerin (BCG) Site Reaction After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination
- Alopecia Areata: An Updated Review for 2023
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19)
- Rehabilitation therapy for a severe case of coronavirus disease 2019: a case report
- Knowledge, Attitude, and Practice Regarding COVID-19 Skin Manifestations among Doctors Working at Khartoum Dermatology and Venereology Teaching Hospital, 2021
- TRANSMEDCON 2022: E-Poster Abstracts
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
- Global Impact of Coronavirus Disease 2019 (COVID-19)
- New Onset of Hair Loss Disorders During the Coronavirus Disease 2019 Pandemic: A Korean Nationwide Population-Based Study
- ANAIS DO I CONGRESSO MÉDICO DE FORMOSA - COMEF
- The study of the range and availability of Vitamin D 3 preparations in the pharmaceutical market of Ukraine
- Serum vitamin D, ferritin, and TSH in patients with telogen effluvium: a retrospective epidemiological study
- Stability Evaluation of Royal Jelly Gel
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Functional characterization of OR51B5 and OR1G1 in human lung epithelial cells as potential drug targets for non-type 2 lung diseases
- Online search interest in long-term symptoms of coronavirus disease 2019 during the COVID-19 pandemic in Japan: Infodemiology study using the most visited search engine in Japan
- Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata
- The 46th Annual Meeting of the Irish Endocrine Society Meeting Programme and Abstracts 2022